Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals A Simulation Study

被引:46
作者
Bellows, Brandon K. [1 ]
Ruiz-Negron, Natalia [2 ,4 ]
Bibbins-Domingo, Kirsten [5 ]
King, Jordan B. [3 ]
Pletcher, Mark J. [5 ]
Moran, Andrew E. [1 ]
Fontil, Valy [6 ]
机构
[1] Columbia Univ, Div Gen Med, 622 W 168th St,PH9-105, New York, NY 10032 USA
[2] Univ Utah, Dept Pharmacotherapy, Salt Lake City, UT USA
[3] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA
[4] SelectHealth, Murray, UT USA
[5] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Div Gen Med, San Francisco, CA 94143 USA
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2019年 / 12卷 / 06期
关键词
adults; blood pressure; cardiovascular disease; hypertension; medication adherence; ANTIHYPERTENSIVE MEDICATION; TREATMENT INTENSIFICATION; HYPERTENSIVE PATIENTS; COST-EFFECTIVENESS; ADHERENCE; ASSOCIATION; PERSISTENCE; PREVENTION; ADULTS; RISK;
D O I
10.1161/CIRCOUTCOMES.118.005624
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Centers for Disease Control and Prevention's Million Hearts initiative includes an ambitious >= 80% blood pressure control goal in US adults with hypertension by 2022. We used the validated Blood Pressure Control Model to quantify changes in clinic-based hypertension management processes needed to attain >= 80% blood pressure control. Methods and Results: The Blood Pressure Control Model simulates patient blood pressures weekly using 3 key modifiable hypertension management processes: office visit frequency, clinician treatment intensification given uncontrolled blood pressure, and continued antihypertensive medication use (medication adherence rate). We compared blood pressure control rates (using the Seventh Joint National Committee on hypertension targets) achieved over 4 years between usual care and the best-observed values for management processes identified from the literature (1-week return visit interval, 20%-44% intensification rate, and 76% adherence rate). We determined the management process values needed to achieve >= 80% blood pressure control in US adults. In adults with uncontrolled blood pressure, usual care achieved 45.6% control (95% uncertainty interval, 39.6%-52.5%) and literature-based best-observed values achieved 79.7% control (95% uncertainty interval, 79.3%-80.1%) over 4 years. Increasing treatment intensification rates to 62% of office visits with an uncontrolled blood pressure resulted in >= 80% blood pressure control, even when the return visit interval and adherence remained at usual care values. Improving to best-observed values for all 3 management processes would achieve 78.1% blood pressure control in the overall US population with hypertension, approaching the >= 80% Million Hearts 2022 goal. Conclusions: Achieving the Million Hearts blood pressure control goal by 2022 will require simultaneously increasing visit frequency, overcoming therapeutic inertia, and improving patient medication adherence. As the relative importance of each of these 3 processes will depend on local characteristics, simulation models like the Blood Pressure Control Model can help local healthcare systems tailor strategies to reach local and national benchmarks.
引用
收藏
页数:10
相关论文
共 46 条
  • [1] Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI [10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000530]
  • [2] Multi-ethnic study of atherosclerosis: Objectives and design
    Bild, DE
    Bluemke, DA
    Burke, GL
    Detrano, R
    Roux, AVD
    Folsom, AR
    Greenland, P
    Jacobs, DR
    Kronmal, R
    Liu, K
    Nelson, JC
    O'Leary, D
    Saad, MF
    Shea, S
    Szklo, M
    Tracy, RP
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) : 871 - 881
  • [3] Continuation of initial antihypertensive medication after 1 year of therapy
    Bloom, BS
    [J]. CLINICAL THERAPEUTICS, 1998, 20 (04) : 671 - 681
  • [4] Failure to intensify antihypertensive treatment by primary care providers: A cohort study in adults with diabetes mellitus and hypertension
    Bolen, Shari Danielle
    Samuels, T. Alafia
    Yeh, Hsin-Chieh
    Marinopoulos, Spyridon S.
    McGuire, Maura
    Abuid, Marcela
    Brancati, Frederick L.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (05) : 543 - 550
  • [5] Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
    Bress, A. P.
    Bellows, B. K.
    King, J. B.
    Hess, R.
    Beddhu, S.
    Zhang, Z.
    Berlowitz, D. R.
    Conroy, M. B.
    Fine, L.
    Oparil, S.
    Morisky, D. E.
    Kazis, L. E.
    Ruiz-Negron, N.
    Powell, J.
    Tamariz, L.
    Whittle, J.
    Wright, J. T., Jr.
    Supiano, M. A.
    Cheung, A. K.
    Weintraub, W. S.
    Moran, A. E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (08) : 745 - 755
  • [6] Economic benefits associated with beta blocker persistence in the treatment of hypertension: a retrospective database analysis
    Chen, Stephanie
    Swallow, Elyse
    Li, Nanxin
    Faust, Elizabeth
    Kelley, Caroline
    Xie, Jipan
    Wu, Eric
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (04) : 615 - 622
  • [7] Real-world adherence and persistence associated with nebivolol or hydrochlorothiazide as add-on treatment for hypertension
    Chen, Stephanie
    Macaulay, Dendy
    Swallow, Elyse
    Diener, Melissa
    Farooqui, Saif
    Xie, Jipan
    Wu, Eric Q.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (04) : 637 - 643
  • [8] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [9] The Association Between Medication Adherence and Treatment Intensification With Blood Pressure Control in Resistant Hypertension
    Daugherty, Stacie L.
    Powers, J. David
    Magid, David J.
    Masoudi, Frederick A.
    Margolis, Karen L.
    O'Connor, Patrick J.
    Schmittdiel, Julie A.
    Ho, P. Michael
    [J]. HYPERTENSION, 2012, 60 (02) : 303 - +
  • [10] Modeled Health and Economic Impact of Team-Based Care for Hypertension
    Dehmer, Steven P.
    Baker-Goering, Madeleine M.
    Maciosek, Michael V.
    Hong, Yuling
    Kottke, Thomas E.
    Margolis, Karen L.
    Will, Julie C.
    Flottemesch, Thomas J.
    LaFrance, Amy B.
    Martinson, Brian C.
    Thomas, Avis J.
    Roy, Kakoli
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2016, 50 (05) : S34 - S44